Oxford unicompartmental knee replacement (OUKR) has shown excellent long-term clinical outcomes as well as implant survival when used for correct indications with optimal surgical technique. Anteromedial osteoarthritis is highly prevalent in Indian patients, and OUKR is the ideal treatment option in such cases. Uncertainty prevails about the best method to determine femoral component size in OUKR. Preoperative templating has been shown to be inaccurate, while height- and gender-based guidelines based on European population might not apply to the Indian patients. Microplasty instrumentation introduced in 2012 introduced the sizing spoon, which has the dual function of femoral component sizing and determining the level of tibia cut. We aimed to check the accuracy of sizing spoon and also to determine whether the present guidelines are appropriate for use in the Indian patients. A total of 130 consecutive Oxford mobile bearing medial cemented UKR performed using the Microplasty instrumentation were included. The ideal femoral component size for each knee was recorded by looking for overhang and underhang in post-operative lateral knee radiograph. The accuracy of previous guidelines was determined by applying them to our study population. Previously published guidelines (which were based on Western population) proved to be accurate in only 37% of cases. Hence, based on the demographics of our study population, we formulated modified height- and gender-based guidelines, which would better suit the Indian population. Accuracy of modified guidelines was estimated to be 74%. The overall accuracy of sizing spoon (75%), when used as an intraoperative guide, was similar to that of modified guidelines. Existing guidelines for femoral component sizing do not work in Indian patients. Modified guidelines and use of intraoperative spoon should be used to choose the optimal implant size while performing OUKR in Indian patients.
Background:The Oxford unicompartmental knee replacement (OUKR) has achieved excellent functional outcomes and long term survivorship in many single center and single surgeon series. However, in national registries, the failure rates are up to three times higher than total knee replacement. This is at least in part due to difficulty experienced by low-volume surgeons in implanting the prosthesis accurately. A new instrumentation system (Microplasty) was introduced to help surgeons achieve better component positioning, however, it is not known whether the new instruments achieve that goal. This study investigates whether the new system achieves better component positioning and whether it improves the clinical outcomes when compared to the existing instruments.Materials and Methods:This retrospective cohort study compared 50 consecutive OUKR implanted using the conventional Phase 3 instrumentation with 100 consecutive OUKR implanted using the new Microplasty instrumentation. Component orientation was measured on postoperative radiographs, and the percentage outside the recommended range was identified. Intraoperative data and retrospectively collected clinical data were also analyzed.Results:Femoral component alignment improved significantly, and there were no outliers in the Microplasty group. Although there were fewer tibial component alignment outliers with Microplasty, the difference was not significant. The intraoperative incidence of tibial recut, patient satisfaction and patient expectations was significantly better in the Microplasty group. The Oxford Knee Scores were also better with Microplasty, however, the difference was not significant.Conclusion:Microplasty instrumentation helps the surgeon achieve optimal component positioning and reduces the need for tibial recut. The clinical outcomes are also better with the Microplasty instrumentation.
This study provides evidence that abnormal knee kinematics, in particular bearing excursion and positioning, are associated with worse functional outcomes after mobile UKA.
Biological therapy with TNF-α inhibitors have been increasingly used in the treatment of inflammatory arthritis. Systemic tuberculosis infections are often known to occur following treatment with these biological agents. However, no case of periprosthetic tuberculous infection of the hip following this therapy has been reported. We report a case of a 45-year-old man who developed periprosthetic tuberculous infection soon after infliximab injection. We also discuss the need of pretreatment awareness, high index of suspicion, early diagnosis and management of such case.
We wish to congratulate the authors for the successful publication of the article titled ‘Assessment of Acute Lesions of the Biceps Pulley in Patients with Traumatic Shoulder Dislocation Using MR Imaging’ [...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.